
Silvia de Sanjosé, premio Jaume I 2025 a la Investigación Clínica y la Salud Pública
Silvia de Sanjosé, Epidemioga specialized in the Human Papillomavirus (HPV) and in associated cancer an east, Has been awarded the Jaume I Prize in the category of clinical research and public health. With 35 years of experience, Isglobal’s research is also an associated professor at the University of Washington and